AtriCure provides innovative technologies for the treatment of Afib and related conditions. The Isolator® Synergy™ Ablation System is FDA approved for the treatment of persistent Afib. AtriCure’s AtriClip Left Atrial Appendage (LAA) Exclusion System products are the most widely sold LAA management devices worldwide, with more than 170,000 implanted.